Main Article Content
BACKGROUND: Patient with hemodialysis (HD) is prone to central venous stenosis (CVS). The presence of CVS contributed to poor dialysis adequacy. Symptomatic CVS is treated with percutaneous transluminal angioplasty (PTA) with or without a stent. This report aimed to understand the characteristics of PTA with or without a stent.
CASE PRESENTATION: A 43-year-old woman was admitted to the hospital with a chief complaint of a deteriorating swollen right arm with pain 1 week prior. Patient had been on HD since 2019, had AV shunt access, continuous ambulatory peritoneal dialysis (CAPD), and 4 times balloon angioplasty due to similar complaints. Diagnoses of the patient were AV shunt stenosis, chronic kidney disease Stage 5 on CAPD, heart failure Stage C FC II, hypertension on treatment, anemia related to renal disease, and severe hypoalbuminemia based on anamnesis and extensive examination. PTA with stent was conducted in this patient and showed TIMI Flow III.
CONCLUSION: PTA is the primary treatment for symptomatic CVS. A stent implantation is used in cases that failed PTA treatment. PTA with a stent provides immediate symptom alleviation and benefits an angioplasty-resistant lesion by secondary patency.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Cantador AA, Pinheiro LL, Guillaumon AT. Endovascular treatment of central vein occlusion in patients with functioning arteriovenous fistulas. J Vasc Bras. 2022;21:e20210130. https://doi.org/10.1590/1677-5449.210130 PMid:35399342 DOI: https://doi.org/10.1590/1677-5449.210130
Dhamija R, Asif A. Central venous stenosis. In: Yevzlin AS, Salman L, Ramani K, Qaqish SS, Vachharajani TJ, editors. Interventional Nephrology: Principles and Practice. Cham: Springer International Publishing; 2022. p. 141-2. https://doi.org/10.1007/978-3-030-81155-6_18 DOI: https://doi.org/10.1007/978-3-030-81155-6_18
Horikawa M, Quencer KB. Central venous interventions. Tech Vasc Interv Radiol. 2017;20(1):48-57. https://doi.org/10.1053/j.tvir.2016.11.006 PMid:28279409 DOI: https://doi.org/10.1053/j.tvir.2016.11.006
Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4 Suppl 2):S1-164. https://doi.org/10.1053/j.ajkd.2019.12.001 PMid:32778223 DOI: https://doi.org/10.1053/j.ajkd.2019.12.001
Horita Y. Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients. J Vasc Access. 2019;20(1 suppl):87-92. https://doi.org/10.1177/1129729817747545 PMid:29529914 DOI: https://doi.org/10.1177/1129729817747545
Kaw LL Jr., Manapat AE, Maglaya PL. Treatment options for hemodialysis-related central vein occlusive disease: Case series and review of literature. Acta Med Philipp. 2023;1-6. https://doi.org/10.47895/amp.vi0.5002 DOI: https://doi.org/10.47895/amp.vi0.5002
Ashwal AJ, Razak UK, Padmakumar R, Pai U, Sudhakar M. Percutaneous intervention for symptomatic central vein stenosis in patients with upper limb arteriovenous dialysis access. Indian Heart J. 2018;70(5):690-8. https://doi.org/10.1016/j.ihj.2018.01.013 PMid:30392508 DOI: https://doi.org/10.1016/j.ihj.2018.01.013
Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: A 10-year single-center experience. AJR Am J Roentgenol. 2009;193(6):1672-9. https://doi.org/10.2214/AJR.09.2654 PMid:19933663 DOI: https://doi.org/10.2214/AJR.09.2654